top of page
Profile
Join date: Aug 21, 2020
Posts (36)
Jul 31, 2024 ∙ 3 min
Resoundant Appoints Kay Pepin, PhD, as Chief Operating Officer
Rochester, MN – July 30, 2024 – Resoundant, Inc., a leader in the development and implementation of advanced magnetic resonance...
122
1
Mar 15, 2024 ∙ 3 min
Resoundant Applauds FDA Approval of Resmetirom: A Milestone for MASLD and MASH Patients
Rochester, MN – Resoundant, a Mayo Clinic company and the developer of Magnetic Resonance Elastography (MRE), is thrilled to announce the...
213
0
Jun 27, 2023 ∙ 2 min
Renaming NAFLD: The Importance and Implications of the Transition to MASLD
The lexicon of medicine is often filled with complex jargon, reflecting the intricacies of human health. Occasionally, these medical...
68
0
Resoundant
Admin
More actions
bottom of page